Semin Perinatol. 2018 Oct 2. pii: S0146-0005(18)30081-8. doi: 10.1053/j.semperi.2018.09.003. [Epub ahead of print]
CRISPR/Cas9 gene-editing: Research technologies, clinical applications and ethical considerations.
Gene therapy carries the potential to treat more than 10,000 human monogenic diseases and benefit an even greater number of complex polygenic conditions. The repurposing of CRISPR/Cas9, an ancient bacterial immune defense system, into a gene-editing technology has armed researchers with a revolutionary tool for gene therapy. However, as the breadth of research and clinical applications of this technology continues to expand, outstanding technical challenges and ethical considerations will need to be addressed before clinical applications become commonplace. Here, we review CRISPR/Cas9 technology and discuss its benefits and limitations in research and the clinical context, as well as ethical considerations surrounding the use of CRISPR gene editing.